NCT03653260View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Zingo in Chinese Children

PHASE3CompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

May 21, 2019

Conditions
Catheter Site PainPain, AcuteAnesthesia, Local
Interventions
DRUG

Lidocaine (Zingo)

0.5 mg lidocaine, 20 bar pressure

DRUG

Placebo

Placebo injector, 20 Bar pressure, empty injector

Trial Locations (1)

Unknown

Shanghai Children's Medical Center, Shanghai

Sponsors
All Listed Sponsors
collaborator

Zhaoke (Hefei) Pharmaceutical Limited

UNKNOWN

lead

Lee's Pharmaceutical Limited

INDUSTRY